India Vaccine Maker Reverses Course, Stops Testing Astra Shots
Technicians inspect vaccine vials during a screening process at the Serum Institute of India Ltd. pharmaceutical plant in Pune, India. (Photographer: Sanjit Das/Bloomberg)

India Vaccine Maker Reverses Course, Stops Testing Astra Shots

(Bloomberg) -- The Indian company enlisted to manufacture a billion doses of AstraZeneca Plc’s experimental Covid-19 vaccine is pausing its own clinical trial, after earlier declaring it would push...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.